世界の次世代シーケンシング市場2021-2028:技術別(ターゲットシーケンシング・リシーケンシング)、用途別(腫瘍、コンシューマーゲノミクス)、ワークフロー別、最終用途別

◆英語タイトル:Next Generation Sequencing Market Size, Share & Trends Analysis Report By Technology (Targeted Sequencing & Resequencing), By Application (Oncology, Consumer Genomics), By Workflow, By End-use, And Segment Forecasts, 2021 - 2028
◆商品コード:GV21MC038
◆発行会社(リサーチ会社):Grand View Research
◆発行日:2021年2月26日
◆ページ数:328
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥684,250見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥799,250見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥1,029,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGrand View Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Grand View Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

グランドビューリサーチ社は、世界の次世代シーケンシング市場規模が年平均14.4%成長し、2028年までに117億ドルに達すると予測しています。本調査レポートでは、次世代シーケンシングの世界市場について調査・分析し、調査手法・範囲、エグゼクティブサマリー、市場変動・動向・範囲、競争分析、技術別(全ゲノムシーケンシング、全エクソームシーケンシング、ターゲットシーケンシング・リシーケンシング)分析、用途別(腫瘍、臨床調査、リプロダクティブ・ヘルス、HLAタイピング/免疫システム、メタゲノミクス・疫学・医薬品開発)分析、ワークフロー別(プレシーケンシング、シーケンシング、NGSデータ分析)分析、最終用途別(学術研究、臨床研究、病院・診療所、製薬・バイオテクノロジー事業体、その他)分析、地域別分析、競争状況などを掲載しています。
・調査手法・範囲
・エグゼクティブサマリー
・市場変動・動向・範囲
・競争分析
・次世代シーケンシングの世界市場規模:技術別(全ゲノムシーケンシング、全エクソームシーケンシング、ターゲットシーケンシング・リシーケンシング)
・次世代シーケンシングの世界市場規模:用途別(腫瘍、臨床調査、リプロダクティブ・ヘルス、HLAタイピング/免疫システム、メタゲノミクス・疫学・医薬品開発)
・次世代シーケンシングの世界市場規模:ワークフロー別(プレシーケンシング、シーケンシング、NGSデータ分析)
・次世代シーケンシングの世界市場規模:最終用途別(学術研究、臨床研究、病院・診療所、製薬・バイオテクノロジー事業体、その他)
・次世代シーケンシングの世界市場規模:地域別
・競争状況
【レポートの概要】

Next Generation Sequencing Market Growth & Trends

The global next generation sequencing market size is anticipated to reach USD 11.7 billion by 2028 registering a CAGR of 14.4%, according to a new report by Grand View Research, Inc. As researchers are continuously unlocking the genetic diversity, the development of targeted therapies is on the rise. These therapies are targeted towards narrow populations of patients that have specific or rare genomic biomarkers. Therefore, this is expected to increase the utilization of next generation sequencing (NGS) technology for targeted therapies.

Simplification in the NGS workflow coupled with the continued price reductions in instruments as well as reagents is attributed to the increasing adoption of this technology. The cost of sequencing the human genome has reduced from USD 100 million to less than USD 1,000 in less than two decades. Moreover, enhancement in the bioinformatics capabilities will lead to broadening of NGS adoption at the low- and high-throughput ends of the research market.

Several companies are engaged in the innovation of long-read sequencing technologies, which will augment the research as well as clinical application sets. The growing automation in the pre- & post-sequencing protocols, and data analysis is also driving the market. The utilization of novel platforms for the development of personalized medicine at a genetic level is also a significant factor, which is expected to boost the demand for NGS over the forecast period.

Next Generation Sequencing Market Report Highlights

• The oncology application segment accounted for the largest revenue share in 2020 and will retain its dominance throughout the forecast period due to the development and launch of targeted gene panels for oncology

• Companies like Myriad Genetics, Inc., through its myRisk product, offer genetic testing to identify people who may be at a higher risk of developing certain cancers in the future

• The high utility of NGS technology in the identification of coronavirus strains is expected to drive the infectious diseases segment with the fastest CAGR from 2021 to 2028

• Sequencing was the largest revenue-generating workflow segment in 2020 due to the introduction of novel, portable sequencers as a result of high competition

• In addition, owing to the expected increase in adoption and usage of WGS, sequencing is expected to witness the fastest CAGR over the forecast period

• The clinical research end-use segment is expected to register the fastest CAGR from 2021 to 2028. An increase in the utility of NGS technology and the support of key players for Covid-19 research is responsible for the segment growth

• For instance, in January 2021, to support the Covid-19 surveillance and research, Thermo Fisher Scientific extended its SARS-CoV-2 GlobalAccess Sequencing Program to offer additional units of Ion GeneStudio S5 sequencer and Ion Torrent Genexus System at a subsidized rate

• North America was the largest regional market owing to significant developments in the fields of companion diagnostics, personalized medicine, and NGS

• Asia Pacific is projected to be the fastest-growing regional market from 2021 to 2028 owing to the expansion of the molecular diagnostics field and high investments by global and local players in the Asian countries

• For instance, in January 2021, Crown Bioscience, Inc.; a U.S.-based platform technology innovator; launched NGS panel services at its Center of Translational Science in Suzhou, China

【レポートの目次】

List of Tables

TABLE 1 List of Secondary Sources
TABLE 2 Country share estimation
TABLE 3 Healthcare expenditure, 2015
TABLE 4 NGS top platforms
TABLE 5 Base pairs sequenced using WGS, WES, and targeted sequencing &resequencing
TABLE 6 Clonal amplification products in the market
TABLE 7 North America next generation sequencing market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 8 North America next generation sequencing for oncology market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 9 North America next generation sequencing for oncology diagnostics & screening market, by application, 2017 - 2028 (USD Million)
TABLE 10 North America next generation sequencing for oncology screening market, by application, 2017 - 2028 (USD Million)
TABLE 11 North America NGS clinical investigation market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 12 North America NGS reproductive health market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 13 North America next generation sequencing NIPT market, by application, 2017 - 2028 (USD Million)
TABLE 14 North America next generation sequencing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 15 North America targeted sequencing/resequencing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 16 North America next generation sequencing market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 17 North America NGS pre-sequencing market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 18 North America NGS data analysis market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 19 North America next generation sequencing market estimates & forecasts, by end-use, 2017 - 2028 (USD Million)
TABLE 20 The U.S. next generation sequencing market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 21 The U.S. next generation sequencing for oncology market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 22 The U.S. next generation sequencing for oncology diagnostics & screening market, by application, 2017 - 2028 (USD Million)
TABLE 23 The U.S. next generation sequencing for oncology screening market, by application, 2017 - 2028 (USD Million)
TABLE 24 The U.S. NGS clinical investigation market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 25 The U.S. NGS reproductive health market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 26 The U.S. next generation sequencing NIPT market, by application, 2017 - 2028 (USD Million)
TABLE 27 The U.S. next generation sequencing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 28 The U.S. targeted sequencing/resequencing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 29 The U.S. next generation sequencing market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 30 The U.S. NGS pre-sequencing market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 31 The U.S. NGS data analysis market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 32 The U.S. next generation sequencing market estimates & forecasts, by end-use, 2017 - 2028 (USD Million)
TABLE 33 Canada next generation sequencing market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 34 Canada next generation sequencing for oncology market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 35 Canada next generation sequencing for oncology diagnostics & screening market, by application, 2017 - 2028 (USD Million)
TABLE 36 Canada next generation sequencing for oncology screening market, by application, 2017 - 2028 (USD Million)
TABLE 37 Canada NGS clinical investigation market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 38 Canada NGS reproductive health market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 39 Canada next generation sequencing NIPT market, by application, 2017 - 2028 (USD Million)
TABLE 40 Canada next generation sequencing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 41 Canada targeted sequencing/resequencing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 42 Canada next generation sequencing market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 43 Canada NGS pre-sequencing market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 44 Canada NGS data analysis market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 45 Canada next generation sequencing market estimates & forecasts, by end-use, 2017 - 2028 (USD Million)
TABLE 46 Europe next generation sequencing market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 47 Europe next generation sequencing for oncology market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 48 Europe next generation sequencing for oncology diagnostics & screening market, by application, 2017 - 2028 (USD Million)
TABLE 49 Europe next generation sequencing for oncology screening market, by application, 2017 - 2028 (USD Million)
TABLE 50 Europe NGS clinical investigation market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 51 Europe NGS reproductive health market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 52 Europe next generation sequencing NIPT market, by application, 2017 - 2028 (USD Million)
TABLE 53 Europe next generation sequencing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 54 Europe targeted sequencing/resequencing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 55 Europe next generation sequencing market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 56 Europe NGS pre-sequencing market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 57 Europe NGS data analysis market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 58 Europe next generation sequencing market estimates & forecasts, by end-use, 2017 - 2028 (USD Million)
TABLE 59 Germany next generation sequencing market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 60 Germany next generation sequencing for oncology market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 61 Germany next generation sequencing for oncology diagnostics & screening market, by application, 2017 - 2028 (USD Million)
TABLE 62 Germany next generation sequencing for oncology screening market, by application, 2017 - 2028 (USD Million)
TABLE 63 Germany NGS clinical investigation market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 64 Germany NGS reproductive health market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 65 Germany next generation sequencing NIPT market, by application, 2017 - 2028 (USD Million)
TABLE 66 Germany next generation sequencing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 67 Germany targeted sequencing/resequencing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 68 Germany next generation sequencing market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 69 Germany NGS pre-sequencing market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 70 Germany NGS data analysis market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 71 Germany next generation sequencing market estimates & forecasts, by end-use, 2017 - 2028 (USD Million)
TABLE 72 The U.K. next generation sequencing market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 73 The U.K. next generation sequencing for oncology market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 74 The U.K. next generation sequencing for oncology diagnostics & screening market, by application, 2017 - 2028 (USD Million)
TABLE 75 The U.K. next generation sequencing for oncology screening market, by application, 2017 - 2028 (USD Million)
TABLE 76 The U.K. NGS clinical investigation market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 77 The U.K. NGS reproductive health market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 78 The U.K. next generation sequencing NIPT market, by application, 2017 - 2028 (USD Million)
TABLE 79 The U.K. next generation sequencing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 80 The U.K. targeted sequencing/resequencing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 81 The U.K. next generation sequencing market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 82 The U.K. NGS pre-sequencing market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 83 The U.K. NGS data analysis market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 84 The U.K. next generation sequencing market estimates & forecasts, by end-use, 2017 - 2028 (USD Million)
TABLE 85 Spain next generation sequencing market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 86 Spain next generation sequencing for oncology market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 87 Spain next generation sequencing for oncology diagnostics & screening market, by application, 2017 - 2028 (USD Million)
TABLE 88 Spain next generation sequencing for oncology screening market, by application, 2017 - 2028 (USD Million)
TABLE 89 Spain NGS clinical investigation market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 90 Spain NGS reproductive health market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 91 Spain next generation sequencing NIPT market, by application, 2017 - 2028 (USD Million)
TABLE 92 Spain next generation sequencing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 93 Spain targeted sequencing/resequencing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 94 Spain next generation sequencing market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 95 Spain NGS pre-sequencing market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 96 Spain NGS data analysis market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 97 Spain next generation sequencing market estimates & forecasts, by end-use, 2017 - 2028 (USD Million)
TABLE 98 France next generation sequencing market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 99 France next generation sequencing for oncology market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 100 France next generation sequencing for oncology diagnostics & screening market, by application, 2017 - 2028 (USD Million)
TABLE 101 France next generation sequencing for oncology screening market, by application, 2017 - 2028 (USD Million)
TABLE 102 France NGS clinical investigation market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 103 France NGS reproductive health market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 104 France next generation sequencing NIPT market, by application, 2017 - 2028 (USD Million)
TABLE 105 France next generation sequencing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 106 France targeted sequencing/resequencing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 107 France next generation sequencing market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 108 France NGS pre-sequencing market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 109 France NGS data analysis market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 110 France next generation sequencing market estimates & forecasts, by end-use, 2017 - 2028 (USD Million)
TABLE 111 Italy next generation sequencing market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 112 Italy next generation sequencing for oncology market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 113 Italy next generation sequencing for oncology diagnostics & screening market, by application, 2017 - 2028 (USD Million)
TABLE 114 Italy next generation sequencing for oncology screening market, by application, 2017 - 2028 (USD Million)
TABLE 115 Italy NGS clinical investigation market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 116 Italy NGS reproductive health market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 117 Italy next generation sequencing NIPT market, by application, 2017 - 2028 (USD Million)
TABLE 118 Italy next generation sequencing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 119 Italy targeted sequencing/resequencing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 120 Italy next generation sequencing market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 121 Italy NGS pre-sequencing market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 122 Italy NGS data analysis market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 123 Italy next generation sequencing market estimates & forecasts, by end-use, 2017 - 2028 (USD Million)
TABLE 124 Asia Pacific next generation sequencing market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 125 Asia Pacific next generation sequencing for oncology market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 126 Asia Pacific next generation sequencing for oncology diagnostics & screening market, by application, 2017 - 2028 (USD Million)
TABLE 127 Asia Pacific next generation sequencing for oncology screening market, by application, 2017 - 2028 (USD Million)
TABLE 128 Asia Pacific NGS clinical investigation market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 129 Asia Pacific NGS reproductive health market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 130 Asia Pacific next generation sequencing NIPT market, by application, 2017 - 2028 (USD Million)
TABLE 131 Asia Pacific next generation sequencing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 132 Asia Pacific targeted sequencing/resequencing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 133 Asia Pacific next generation sequencing market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 134 Asia Pacific NGS pre-sequencing market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 135 Asia Pacific NGS data analysis market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 136 Asia Pacific next generation sequencing market estimates & forecasts, by end-use, 2017 - 2028 (USD Million)
TABLE 137 Japan next generation sequencing market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 138 Japan next generation sequencing for oncology market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 139 Japan next generation sequencing for oncology diagnostics & screening market, by application, 2017 - 2028 (USD Million)
TABLE 140 Japan next generation sequencing for oncology screening market, by application, 2017 - 2028 (USD Million)
TABLE 141 Japan NGS clinical investigation market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 142 Japan NGS reproductive health market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 143 Japan next generation sequencing NIPT market, by application, 2017 - 2028 (USD Million)
TABLE 144 Japan next generation sequencing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 145 Japan targeted sequencing/resequencing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 146 Japan next generation sequencing market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 147 Japan NGS pre-sequencing market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 148 Japan NGS data analysis market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 149 Japan next generation sequencing market estimates & forecasts, by end-use, 2017 - 2028 (USD Million)
TABLE 150 China next generation sequencing market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 151 China next generation sequencing for oncology market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 152 China next generation sequencing for oncology diagnostics & screening market, by application, 2017 - 2028 (USD Million)
TABLE 153 China next generation sequencing for oncology screening market, by application, 2017 - 2028 (USD Million)
TABLE 154 China NGS clinical investigation market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 155 China NGS reproductive health market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 156 China next generation sequencing NIPT market, by application, 2017 - 2028 (USD Million)
TABLE 157 China next generation sequencing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 158 China targeted sequencing/resequencing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 159 China next generation sequencing market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 160 China NGS pre-sequencing market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 161 China NGS data analysis market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 162 China next generation sequencing market estimates & forecasts, by end-use, 2017 - 2028 (USD Million)
TABLE 163 India next generation sequencing market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 164 India next generation sequencing for oncology market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 165 India next generation sequencing for oncology diagnostics & screening market, by application, 2017 - 2028 (USD Million)
TABLE 166 India next generation sequencing for oncology screening market, by application, 2017 - 2028 (USD Million)
TABLE 167 India NGS clinical investigation market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 168 India NGS reproductive health market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 169 India next generation sequencing NIPT market, by application, 2017 - 2028 (USD Million)
TABLE 170 India next generation sequencing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 171 India targeted sequencing/resequencing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 172 India next generation sequencing market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 173 India NGS pre-sequencing market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 174 India NGS data analysis market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 175 India next generation sequencing market estimates & forecasts, by end-use, 2017 - 2028 (USD Million)
TABLE 176 South Korea next generation sequencing market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 177 South Korea next generation sequencing for oncology market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 178 South Korea next generation sequencing for oncology diagnostics & screening market, by application, 2017 - 2028 (USD Million)
TABLE 179 South Korea next generation sequencing for oncology screening market, by application, 2017 - 2028 (USD Million)
TABLE 180 South Korea NGS clinical investigation market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 181 South Korea NGS reproductive health market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 182 South Korea next generation sequencing NIPT market, by application, 2017 - 2028 (USD Million)
TABLE 183 South Korea next generation sequencing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 184 South Korea targeted sequencing/resequencing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 185 South Korea next generation sequencing market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 186 South Korea NGS pre-sequencing market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 187 South Korea NGS data analysis market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 188 South Korea next generation sequencing market estimates & forecasts, by end-use, 2017 - 2028 (USD Million)
TABLE 189 Australia next generation sequencing market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 190 Australia next generation sequencing for oncology market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 191 Australia next generation sequencing for oncology diagnostics & screening market, by application, 2017 - 2028 (USD Million)
TABLE 192 Australia next generation sequencing for oncology screening market, by application, 2017 - 2028 (USD Million)
TABLE 193 Australia NGS clinical investigation market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 194 Australia NGS reproductive health market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 195 Australia next generation sequencing NIPT market, by application, 2017 - 2028 (USD Million)
TABLE 196 Australia next generation sequencing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 197 Australia targeted sequencing/resequencing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 198 Australia next generation sequencing market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 199 Australia NGS pre-sequencing market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 200 Australia NGS data analysis market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 201 Australia next generation sequencing market estimates & forecasts, by end-use, 2017 - 2028 (USD Million)
TABLE 202 Latin America next generation sequencing market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 203 Latin America next generation sequencing for oncology market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 204 Latin America next generation sequencing for oncology diagnostics & screening market, by application, 2017 - 2028 (USD Million)
TABLE 205 Latin America next generation sequencing for oncology screening market, by application, 2017 - 2028 (USD Million)
TABLE 206 Latin America NGS clinical investigation market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 207 Latin America NGS reproductive health market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 208 Latin America next generation sequencing NIPT market, by application, 2017 - 2028 (USD Million)
TABLE 209 Latin America next generation sequencing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 210 Latin America targeted sequencing/resequencing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 211 Latin America next generation sequencing market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 212 Latin America NGS pre-sequencing market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 213 Latin America NGS data analysis market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 214 Latin America next generation sequencing market estimates & forecasts, by end-use, 2017 - 2028 (USD Million)
TABLE 215 Brazil next generation sequencing market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 216 Brazil next generation sequencing for oncology market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 217 Brazil next generation sequencing for oncology diagnostics & screening market, by application, 2017 - 2028 (USD Million)
TABLE 218 Brazil next generation sequencing for oncology screening market, by application, 2017 - 2028 (USD Million)
TABLE 219 Brazil NGS clinical investigation market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 220 Brazil NGS reproductive health market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 221 Brazil next generation sequencing NIPT market, by application, 2017 - 2028 (USD Million)
TABLE 222 Brazil next generation sequencing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 223 Brazil targeted sequencing/resequencing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 224 Brazil next generation sequencing market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 225 Brazil NGS pre-sequencing market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 226 Brazil NGS data analysis market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 227 Brazil next generation sequencing market estimates & forecasts, by end-use, 2017 - 2028 (USD Million)
TABLE 228 Mexico next generation sequencing market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 229 Mexico next generation sequencing for oncology market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 230 Mexico next generation sequencing for oncology diagnostics & screening market, by application, 2017 - 2028 (USD Million)
TABLE 231 Mexico next generation sequencing for oncology screening market, by application, 2017 - 2028 (USD Million)
TABLE 232 Mexico NGS clinical investigation market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 233 Mexico NGS reproductive health market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 234 Mexico next generation sequencing NIPT market, by application, 2017 - 2028 (USD Million)
TABLE 235 Mexico next generation sequencing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 236 Mexico targeted sequencing/resequencing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 237 Mexico next generation sequencing market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 238 Mexico NGS pre-sequencing market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 239 Mexico NGS data analysis market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 240 Mexico next generation sequencing market estimates & forecasts, by end-use, 2017 - 2028 (USD Million)
TABLE 241 MEA next generation sequencing market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 242 MEA next generation sequencing for oncology market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 243 MEA next generation sequencing for oncology diagnostics & screening market, by application, 2017 - 2028 (USD Million)
TABLE 244 MEA next generation sequencing for oncology screening market, by application, 2017 - 2028 (USD Million)
TABLE 245 MEA NGS clinical investigation market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 246 MEA NGS reproductive health market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 247 MEA next generation sequencing NIPT market, by application, 2017 - 2028 (USD Million)
TABLE 248 MEA next generation sequencing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 249 MEA targeted sequencing/resequencing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 250 MEA next generation sequencing market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 251 MEA NGS pre-sequencing market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 252 MEA NGS data analysis market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 253 MEA next generation sequencing market estimates & forecasts, by end-use, 2017 - 2028 (USD Million)
TABLE 254 South Africa next generation sequencing market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 255 South Africa next generation sequencing for oncology market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 256 South Africa next generation sequencing for oncology diagnostics & screening market, by application, 2017 - 2028 (USD Million)
TABLE 257 South Africa next generation sequencing for oncology screening market, by application, 2017 - 2028 (USD Million)
TABLE 258 South Africa NGS clinical investigation market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 259 South Africa NGS reproductive health market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 260 South Africa next generation sequencing NIPT market, by application, 2017 - 2028 (USD Million)
TABLE 261 South Africa next generation sequencing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 262 South Africa targeted sequencing/resequencing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 263 South Africa next generation sequencing market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 264 South Africa NGS pre-sequencing market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 265 South Africa NGS data analysis market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 266 South Africa next generation sequencing market estimates & forecasts, by end-use, 2017 - 2028 (USD Million)
TABLE 267 Saudi Arabia next generation sequencing market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 268 Saudi Arabia next generation sequencing for oncology market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 269 Saudi Arabia next generation sequencing for oncology diagnostics & screening market, by application, 2017 - 2028 (USD Million)
TABLE 270 Saudi Arabia next generation sequencing for oncology screening market, by application, 2017 - 2028 (USD Million)
TABLE 271 Saudi Arabia NGS clinical investigation market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 272 Saudi Arabia NGS reproductive health market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 273 Saudi Arabia next generation sequencing NIPT market, by application, 2017 - 2028 (USD Million)
TABLE 274 Saudi Arabia next generation sequencing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 275 Saudi Arabia targeted sequencing/resequencing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 276 Saudi Arabia next generation sequencing market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 277 Saudi Arabia NGS pre-sequencing market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 278 Saudi Arabia NGS data analysis market estimates & forecasts, by workflow, 2017 - 2028 (USD Million)
TABLE 279 Saudi Arabia next generation sequencing market estimates & forecasts, by end-use, 2017 - 2028 (USD Million)

List of Figures

FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain based sizing & forecasting
FIG. 6 QFD modelling for market share assessment
FIG. 7 Market segmentation & scope
FIG. 8 Market summary
FIG. 9 Penetration & growth prospect mapping for applications, 2020
FIG. 10 Penetration & growth prospect mapping for prominent industry players, 2020
FIG. 11 Payer perspectives for developing coverage policy for Next Generation Tumour Sequencing Panels (NGTS)
FIG. 12 Market trends & outlook
FIG. 13 Market driver relevance analysis (Current & future impact)
FIG. 14 Cost per raw megabase (Mb) of DNA sequence (USD)
FIG. 15 Cost per genome
FIG. 16 Expected rise in expenditure for cancer treatment (USD Billion)
FIG. 17 Global cancer prevalence
FIG. 18 Market restraint relevance analysis (Current & future impact)
FIG. 19 Percentage of NGS sequencing reimbursement from payers
FIG. 20 Bottlenecks associated with implementation of NGS
FIG. 21 Porter’s Five Forces Analysis
FIG. 22 PESTEL Analysis
FIG. 23 NGS platform penetration mapping, 2020
FIG. 24 Next generation sequencing market: Regional market share, 2020
FIG. 25 Next generation sequencing Asia Pacific regulatory and political landscape analysis, 2020
FIG. 26 Next generation sequencing Latin America regulatory and political landscape analysis, 2020
FIG. 27 Next generation sequencing Middle East & Africa regulatory and political landscape analysis 2020
FIG. 28 NGS platforms & related products market, 2017 - 2028 (USD Million)
FIG. 29 NGS services market, 2017 - 2028 (USD Million)
FIG. 30 Next generation sequencing market: Application outlook key takeaways
FIG. 31 Next generation sequencing market: Application movement analysis
FIG. 32 Global oncology market, 2017 - 2028 (USD Million)
FIG. 33 Diagnostics and screening market, 2017 - 2028 (USD Million)
FIG. 34 Oncology screening market, 2017 - 2028 (USD Million)
FIG. 35 Sporadic cancer screening market, 2017 - 2028 (USD Million)
FIG. 36 Inherited cancer screening market, 2017 - 2028 (USD Million)
FIG. 37 Companion diagnostics market, 2017 - 2028 (USD Million)
FIG. 38 Other diagnostics market, 2017 - 2028 (USD Million)
FIG. 39 Research studies market, 2017 - 2028 (USD Million)
FIG. 40 Global clinical investigation market, 2017 - 2028 (USD Million)
FIG. 41 Global infectious diseases market, 2017 - 2028 (USD Million)
FIG. 42 Global inherited diseases market, 2017 - 2028 (USD Million)
FIG. 43 Global idiopathic diseases market, 2017 - 2028 (USD Million)
FIG. 44 Global non-communicable/other diseases market, 2017 - 2028 (USD Million)
FIG. 45 Global reproductive health market, 2017 - 2028 (USD Million)
FIG. 46 Global NIPT market, 2017 - 2028 (USD Million)
FIG. 47 Global aneuploidy market, 2017 - 2028 (USD Million)
FIG. 48 Global microdeletions market, 2017 - 2028 (USD Million)
FIG. 49 Global NGS PGT market, 2017 - 2028 (USD Million)
FIG. 50 Global new-born/genetic screening market, 2017 - 2028 (USD Million)
FIG. 51 Single gene analysis market, 2017 - 2028 (USD Million)
FIG. 52 Global HLA typing/immune system monitoring market, 2017 - 2028 (USD Million)
FIG. 53 Global metagenomics, epidemiology & drug development market, 2017 - 2028 (USD Million)
FIG. 54 Global agrigenomics & forensics market, 2017 - 2028 (USD Million)
FIG. 55 Global consumer genomics market, 2017 - 2028 (USD Million)
FIG. 56 Next generation sequencing market: Technology outlook key takeaways
FIG. 57 Global next generation sequencing market: Technology movement analysis
FIG. 58 Global whole genome sequencing market, 2017 - 2028 (USD Million)
FIG. 59 Global whole exome sequencing market, 2017 - 2028 (USD Million)
FIG. 60 Global targeted sequencing & resequencing market, 2017 - 2028 (USD Million)
FIG. 61 Global DNA based targeted sequencing & resequencing market, 2017 - 2028 (USD Million)
FIG. 62 Global RNA based targeted sequencing & resequencing market, 2017 - 2028 (USD Million)
FIG. 63 Next generation sequencing market Workflow outlook key takeaways
FIG. 64 Next generation sequencing market: Workflow movement analysis
FIG. 65 Global pre-sequencing market, 2017 - 2028 (USD Million)
FIG. 66 Global NGS library preparation kits market, 2017 - 2028 (USD Million)
FIG. 67 Global NGS semi-automated library preparation market, 2017 - 2028 (USD Million)
FIG. 68 Global NGS automated library preparation market, 2017 - 2028 (USD Million)
FIG. 69 Global clonal amplification market, 2017 - 2028 (USD Million)
FIG. 70 Global Sequencing market, 2017 - 2028 (USD Million)
FIG. 71 Global data analysis market, 2017 - 2028 (USD Million)
FIG. 72 Global NGS primary data analysis market, 2017 - 2028 (USD Million)
FIG. 73 Global NGS secondary data analysis market, 2017 - 2028 (USD Million)
FIG. 74 Global NGS tertiary data analysis market, 2017 - 2028 (USD Million)
FIG. 75 Next generation sequencing market End-use outlook key takeaways
FIG. 76 Next generation sequencing market: End-use movement analysis
FIG. 77 Global academic research market, 2017 - 2028 (USD Million)
FIG. 78 Global clinical research market, 2017 - 2028 (USD Million)
FIG. 79 Global hospitals & clinics market, 2017 - 2028 (USD Million)
FIG. 80 Global pharma & biotech entities market, 2017 - 2028 (USD Million)
FIG. 81 Global other users market, 2017 - 2028 (USD Million)
FIG. 82 Regional market place: Key takeaway
FIG. 83 Regional Sequencing Capacity Mapping
FIG. 84 Next generation regional outlook, 2020 & 2028
FIG. 85 North America next generation sequencing market, 2017 - 2028 (USD Million)
FIG. 86 The U.S. next generation sequencing market, 2017 - 2028 (USD Million)
FIG. 87 Canada next generation sequencing market, 2017 - 2028 (USD Million)
FIG. 88 Europe next generation sequencing market, 2017 - 2028 (USD Million)
FIG. 89 Germany next generation sequencing market, 2017 - 2028 (USD Million)
FIG. 90 The U.K. next generation sequencing market, 2017 - 2028 (USD Million)
FIG. 91 France next generation sequencing market, 2017 - 2028 (USD Million)
FIG. 92 Italy next generation sequencing market, 2017 - 2028 (USD Million)
FIG. 93 Spain next generation sequencing market, 2017 - 2028 (USD Million)
FIG. 94 Asia Pacific next generation sequencing market, 2017 - 2028 (USD Million)
FIG. 95 Japan next generation sequencing market, 2017 - 2028 (USD Million)
FIG. 96 China next generation sequencing market, 2017 - 2028 (USD Million)
FIG. 97 India next generation sequencing market, 2017 - 2028 (USD Million)
FIG. 98 South Korea next generation sequencing market, 2017 - 2028 (USD Million)
FIG. 99 Australia next generation sequencing market, 2017 - 2028 (USD Million)
FIG. 100 Latin America next generation sequencing market, 2017 - 2028 (USD Million)
FIG. 101 Brazil next generation sequencing market, 2017 - 2028 (USD Million)
FIG. 102 Mexico next generation sequencing market, 2017 - 2028 (USD Million)
FIG. 103 Middle East & Africa next generation sequencing market, 2017 - 2028 (USD Million)
FIG. 104 South Africa next generation sequencing market, 2017 - 2028 (USD Million)
FIG. 105 Saudi Arabia next generation sequencing market, 2017 - 2028 (USD Million)
FIG. 106 Strategy framework
FIG. 107 Participant categorization
FIG. 108 Next-generation sequencing vendor’s landscape
FIG. 109 List of companies

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界の次世代シーケンシング市場2021-2028:技術別(ターゲットシーケンシング・リシーケンシング)、用途別(腫瘍、コンシューマーゲノミクス)、ワークフロー別、最終用途別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆